New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy
Credit: OHSU News
Jared Fischer, Ph.D., left, and Jose Luis Montoya Mira, Ph.D., cancer researchers at OHSU, have developed PAC-MANN, a test that uses a small blood sample to detect changes in protease activity, a key indicator of the most common and deadliest form of pancreatic cancer. (OHSU/Christine Torres Hicks)